Australia's most trusted
source of pharma news
Saturday, 21 June 2025
Posted 18 June 2025 AM
Link-Clinigen Group has officially entered the OTC market with Australia’s first pharmacist-only immediate release melatonin for jet lag.
The approval of Voquily Jet Lag for the relief of jet lag symptoms in adults aged 18 years and above follows the TGA’s decision to down schedule immediate release preparations containing 5 mg or less of melatonin for the indication, in a primary pack containing no more than 10 dosage units in June 2023.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.